Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NWBO | US
-0.00
-1.45%
Healthcare
Biotechnology
30/06/2024
16/04/2026
0.20
0.20
0.20
0.20
Northwest Biotherapeutics Inc. a biotechnology company develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product DCVax-L which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda Maryland.
View LessStrong Revenue Growth (> 10%)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
13.2%1 month
44.1%3 months
47.6%6 months
74.8%-
-
-
-
-
-11.91
262.66
-
-60.47M
247.02M
247.02M
-
-3.42K
-
153.70
-
13.54
15.09
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.03
Range1M
0.04
Range3M
0.12
Rel. volume
0.64
Price X volume
199.66K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Foghorn Therapeutics Inc | FHTX | Biotechnology | 4.86 | 268.90M | -0.21% | n/a | -285.69% |
| Verrica Pharmaceuticals Inc | VRCA | Biotechnology | 6.21 | 264.97M | 5.08% | n/a | -348.20% |
| Compugen Ltd | CGEN | Biotechnology | 2.89 | 258.76M | 0.00% | n/a | 5.19% |
| Verastem Inc | VSTM | Biotechnology | 6.34 | 255.15M | 0.16% | n/a | 104.63% |
| Alector Inc | ALEC | Biotechnology | 2.55 | 248.17M | -1.16% | n/a | 23.98% |
| Prelude Therapeutics Incorporated | PRLD | Biotechnology | 4.43 | 243.76M | -19.75% | n/a | 9.99% |
| Arcturus Therapeutics Ltd | ARCT | Biotechnology | 8.84 | 239.05M | 2.55% | n/a | 11.94% |
| BioAtla Inc. | BCAB | Biotechnology | 4.91 | 237.33M | 8.99% | n/a | 5.30% |
| Abeona Therapeutics Inc | ABEO | Biotechnology | 5.38 | 233.03M | -0.37% | n/a | 31.63% |
| Anika Therapeutics Inc | ANIK | Biotechnology | 15.39 | 227.72M | 0.72% | n/a | 13.35% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Marine Products Corporation | MPX | Recreational Vehicles | 7.63 | 264.90M | 0.39% | 13.23 | 0.00% |
| Urban One Inc | UONEK | Broadcasting - Radio | 4.87 | 258.15M | 0.00% | n/a | 268.43% |
| CPI Card Group Inc | PMTS | Building Products & Equipment | 17.89 | 199.61M | 1.02% | 15.61 | -621.78% |
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 9.74 | 156.39M | 0.72% | n/a | 286.96% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 34.99 | 100.48M | 0.63% | 5.16 | 19.82% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.12 | 99.69M | 0.49% | 9.09 | 39.79% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 11.93 | 74.70M | 1.14% | 14.48 | 7.10% |
| ILAG | ILAG | Building Products & Equipment | 3.32 | 59.96M | 0.00% | n/a | 5.48% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 14 | 21.32M | 2.04% | n/a | 204.46% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.612 | 11.83M | -2.84% | n/a | 58.43% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -11.91 | - | Cheaper |
| Ent. to Revenue | 262.66 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 47.59 | - | Lower Risk |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 247.02M | - | Emerging |